<?xml version="1.0" encoding="UTF-8"?>
<p>Compoundsâ€™ activity against CV-B5, Sb-1, VSV, VV, HSV-1, and RSV was determined by plaque reduction assays in infected cell monolayers, as described previously [
 <xref rid="B39-pathogens-10-00403" ref-type="bibr">39</xref>]. 
</p>
